KORU Medical Systems, Inc. — Form 10-Q
Filed August 5, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Adam Kalbermatten (CEO) and Thomas Adams (CFO) executed standard Sarbanes-Oxley certifications on August 5, 2026 for the quarter ended June 30, 2026. Both officers certified that the 10-Q report contains no untrue material statements, that financial statements fairly present the company's condition, and that disclosure controls and internal controls over financial reporting are effective. No specific financial metrics, transaction details, or control deficiencies were disclosed in these certification exhibits.
Why this rating
Standard SOX 302/906 certifications; routine quarterly filing requirement. No disclosed material changes, transactions, or control weaknesses.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.